FI943765A0 - 4-aminopyridiinin käyttö neurologisen tilan hoidossa - Google Patents

4-aminopyridiinin käyttö neurologisen tilan hoidossa

Info

Publication number
FI943765A0
FI943765A0 FI943765A FI943765A FI943765A0 FI 943765 A0 FI943765 A0 FI 943765A0 FI 943765 A FI943765 A FI 943765A FI 943765 A FI943765 A FI 943765A FI 943765 A0 FI943765 A0 FI 943765A0
Authority
FI
Finland
Prior art keywords
pct
aminopyridine
treatment
neurological condition
sec
Prior art date
Application number
FI943765A
Other languages
English (en)
Swedish (sv)
Other versions
FI943765A (fi
Inventor
Robert Hanselbout
Andrew R Blight
Original Assignee
Canadian Spinal Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Spinal Res Org filed Critical Canadian Spinal Res Org
Publication of FI943765A0 publication Critical patent/FI943765A0/fi
Publication of FI943765A publication Critical patent/FI943765A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FI943765A 1992-12-18 1994-08-16 4-aminopyridiinin käyttö neurologisen tilan hoidossa FI943765A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002085785A CA2085785C (en) 1992-12-18 1992-12-18 The use of 4-aminopyridine in the treatment of a neurological condition
PCT/CA1993/000554 WO1994014439A1 (en) 1992-12-18 1993-12-20 The use of 4-aminopyridine in the treatment of a neurological condition

Publications (2)

Publication Number Publication Date
FI943765A0 true FI943765A0 (fi) 1994-08-16
FI943765A FI943765A (fi) 1994-10-14

Family

ID=4150879

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943765A FI943765A (fi) 1992-12-18 1994-08-16 4-aminopyridiinin käyttö neurologisen tilan hoidossa

Country Status (19)

Country Link
US (1) US5545648A (fi)
EP (1) EP0626848B1 (fi)
JP (1) JP3474569B2 (fi)
KR (1) KR100301415B1 (fi)
AT (1) ATE241981T1 (fi)
AU (1) AU676251B2 (fi)
BG (1) BG62272B1 (fi)
BR (1) BR9305909A (fi)
CA (1) CA2085785C (fi)
CZ (1) CZ284441B6 (fi)
DE (1) DE69333014T2 (fi)
ES (1) ES2199957T3 (fi)
FI (1) FI943765A (fi)
HU (1) HU219583B (fi)
NO (2) NO308644B1 (fi)
NZ (1) NZ258844A (fi)
RU (1) RU2160590C2 (fi)
SK (1) SK280922B6 (fi)
WO (1) WO1994014439A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792743A (en) * 1995-04-19 1998-08-11 Acorda Therapeutics Method for promoting neural growth comprising administering a soluble neural cell adhesion molecule
JPH09315972A (ja) * 1996-03-22 1997-12-09 Chugai Pharmaceut Co Ltd 脊髄損傷治療剤
WO1999004705A1 (en) 1997-07-25 1999-02-04 Tsui Ban C H Devices, systems and methods for determining proper placement of epidural catheters
US7582680B1 (en) 1998-11-12 2009-09-01 Purdue Research Foundation Methods and compositions for treating mammalian spinal cord injuries
WO2000047210A1 (en) * 1999-02-09 2000-08-17 Uab Research Foundation Use of 4-amino pyridine for treatment of peripheral neuropathies
NO324322B1 (no) 2001-02-26 2007-09-24 Dynea Oy Anvendelse av herder samt fremgangsmate ved liming
CA2445612C (en) 2001-04-24 2011-10-25 Purdue Research Foundation Methods and compositions for treating mammalian nerve tissue injuries
US20040047843A1 (en) * 2002-02-12 2004-03-11 Uab Research Foundation Method for spinal cord reconnection
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
WO2004052291A2 (en) * 2002-12-06 2004-06-24 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
JP4533590B2 (ja) * 2003-02-28 2010-09-01 ファイザー株式会社 脊髄損傷患者における疼痛又は痙性軽減用医薬組成物
US20050192321A1 (en) * 2003-09-15 2005-09-01 Meythaler Jay M. Treatment of neuropathy with rapid release aminopyridine
US8007826B2 (en) * 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
US20130030025A1 (en) * 2011-01-28 2013-01-31 Wessel Thomas C Use of potassium channel blockers to treat cerebral palsy
US8924325B1 (en) * 2011-02-08 2014-12-30 Lockheed Martin Corporation Computerized target hostility determination and countermeasure
TWI592156B (zh) * 2011-10-04 2017-07-21 艾可達醫療公司 使用胺基吡啶以治療與中風有關之感覺動作損傷之方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508715A (en) * 1981-07-01 1985-04-02 University Of Georgia Research Foundation, Inc. Antagonism of central nervous system drugs by the administration of 4-aminopyridine alone or in combination with other drugs
WO1989009600A1 (en) * 1988-04-08 1989-10-19 Massachusetts Institute Of Technology Method and composition for treating neurological disorders
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases

Also Published As

Publication number Publication date
BR9305909A (pt) 1997-10-21
EP0626848B1 (en) 2003-06-04
AU5691194A (en) 1994-07-19
ES2199957T3 (es) 2004-03-01
HUT68171A (en) 1995-05-29
NO308644B1 (no) 2000-10-09
FI943765A (fi) 1994-10-14
US5545648A (en) 1996-08-13
ATE241981T1 (de) 2003-06-15
CA2085785C (en) 2005-03-15
DE69333014T2 (de) 2004-05-06
NZ258844A (en) 1997-04-24
NO943049L (no) 1994-10-17
JPH08504772A (ja) 1996-05-21
NO2012003I2 (no) 2013-02-18
WO1994014439A1 (en) 1994-07-07
KR100301415B1 (ko) 2001-11-22
EP0626848A1 (en) 1994-12-07
NO943049D0 (no) 1994-08-17
HU9402647D0 (en) 1994-11-28
RU2160590C2 (ru) 2000-12-20
SK280922B6 (sk) 2000-09-12
CZ225494A3 (en) 1995-03-15
AU676251B2 (en) 1997-03-06
BG99047A (bg) 1995-06-30
RU94041207A (ru) 1996-06-20
BG62272B1 (bg) 1999-07-30
KR950700062A (ko) 1995-01-16
DE69333014D1 (de) 2003-07-10
SK96994A3 (en) 1995-04-12
CA2085785A1 (en) 1994-06-19
JP3474569B2 (ja) 2003-12-08
HU219583B (hu) 2001-05-28
NO2012003I1 (no) 2012-02-13
CZ284441B6 (cs) 1998-11-11

Similar Documents

Publication Publication Date Title
NO2012003I2 (no) 4-aminopyridin
CZ154695A3 (en) The use of anticonvulsive preparations when treating neurological lesions occurring in case of injury
PL309594A1 (en) Apllication of rilusole in treating parkinson disease and parkinsonian syndromes
GR3024787T3 (en) Levobupivacaine useful for managing chronic pain
DE69424777T2 (de) 3,4-diarylchromane zur behandlung von dermatitis
TW261532B (fi)
MD1716B2 (en) Use of melatonin for treatment of patients dependent on benzodiazepine
ATE150645T1 (de) Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen
ATE203671T1 (de) Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen
AU5696594A (en) Triazoloquinazolines for the treatment of diseases of the central vervous system
UA29005A (uk) Спосіб лікування трофічних виразок нижніх кінцівок
UA12425A (uk) Спосіб лікуваhhя субарахhоідальhих крововиливів